Acknowledgements
Johnson & Johnson would like to thank all the people who took part in this study as well as their families and caregivers; the physicians and nurses who cared for the participants as well as the staff at the clinical sites; the scientific staff for their assistance.
Author contributions
The original authors of the full article were involved in preparing this summary.
Disclosure statement
A Chari reports a consulting/advisory role for AbbVie, Antengene, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Johnson & Johnson, Karyopharm Therapeutics, Oncopeptides, Sanofi, Seagen, Secura Bio, Shattuck Bio, Shattuck Labs, and Takeda; and has received research funding from Amgen, Celgene, Johnson & Johnson, Pharmacyclics, Seagen, and Takeda. S Shenoy has received honoraria from Johnson & Johnson. S Kruyswijk reports other support from Johnson & Johnson outside the submitted work. B Hilder and L O’Rourke are employees and stockholders of Johnson & Johnson. NWCJ van de Donk has received research support from AMGEN, BMS, Celgene, Cellectis, Johnson & Johnson, and Novartis; and serves in advisory boards for AbbVie, Adaptive, AMGEN, Bayer, BMS, Celgene, Johnson & Johnson, Kite Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, Servier, and Takeda, all paid to institution. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Summary prepared by Sandi Wong, PhD, of Eloquent, part of Envision Ignite, an Envision Medical Communications agency, a part of Envision Pharma Group, and funded by Johnson & Johnson.
Patient reviewers on this PLSP have received honorarium from Future Oncology for their review work. One peer reviewer on this manuscript has disclosed “Consulting or advisory role: J&J, Prothena, Legend Biotech, Kite. Research: J&J, Prothena, Ascentage, Karyopharm, GPCR therapeutics.” A second peer reviewer on this manuscript has disclosed “Honoraria and Financing of Scientific Research from Janssen.” Patient and peer reviewers on this manuscript have no other relevant financial relationships or otherwise to disclose.
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.
Funding
This manuscript was funded by Johnson & Johnson. The funder was involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.